---
title: "European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280657170.md"
description: "European equities traded in the US saw a decline of 0.56% on the S&P Europe Select ADR Index, reaching 1,718.19, though still up 0.2% for the week. Notable gainers included EDAP TMS (+4.2%) and Novo Nordisk (+2.6%), while Banco Santander (-1.6%) and Cellectis (-1.2%) were among the decliners from continental Europe. In the UK, Akari Therapeutics (+3.2%) and Endava (+3.1%) led the gains, while Silence Therapeutics (-4.9%) and Lloyds Banking Group (-1.5%) were the top decliners."
datetime: "2026-03-26T15:01:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280657170.md)
  - [en](https://longbridge.com/en/news/280657170.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280657170.md)
---

# European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

11:01 AM EDT, 03/26/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were lower late Thursday morning, declining 0.56% to 1,718.19 on the S&P Europe Select ADR Index, which is still up 0.2% for the week so far.

From continental Europe, the gainers were led by medical device maker EDAP TMS ( EDAP ) and pharmaceutical company Novo Nordisk ( NVO ) , which rose 4.2% and 2.6%, respectively. They were followed by internet advertising firm Criteo ( CRTO ) and internet browser company Opera (OPRA), which were up 2.1% and 1.8%, respectively.

The decliners from continental Europe were led by lender Banco Santander (SAN) and biopharmaceutical company Cellectis ( CLLS ) , which dropped 1.6% and 1.2%, respectively. They were followed by lenders Banco Bilbao Vizcaya Argentaria ( BBVA ) and ING Groep ( ING ) , which were off 0.9% and 0.4%, respectively.

The gainers from the UK were led by biopharmaceutical company Akari Therapeutics ( AKTX ) and software firm Endava ( DAVA ) , which advanced 3.2% and 3.1%, respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and biotech firm Trinity Biotech (TRIB), which increased 2.3% and 1.8%, respectively.

The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics ( SLN ) and lender Lloyds Banking Group ( LYG ) , which lost 4.9% and 1.5%, respectively. They were followed by lender Barclays ( BCS ) and utilities company National Grid ( NGG ) , which were down 1.4% each.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [NVOX.US](https://longbridge.com/en/quote/NVOX.US.md)
- [DAVA.US](https://longbridge.com/en/quote/DAVA.US.md)
- [AKTX.US](https://longbridge.com/en/quote/AKTX.US.md)
- [SAN.US](https://longbridge.com/en/quote/SAN.US.md)
- [FDD.US](https://longbridge.com/en/quote/FDD.US.md)
- [SPEU.US](https://longbridge.com/en/quote/SPEU.US.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [LYG.US](https://longbridge.com/en/quote/LYG.US.md)
- [EDAP.US](https://longbridge.com/en/quote/EDAP.US.md)
- [CLLS.US](https://longbridge.com/en/quote/CLLS.US.md)

## Related News & Research

- [Akari Therapeutics to Present at A.G.P.’s Annual Healthcare Company Showcase | AKTX Stock News](https://longbridge.com/en/news/286776452.md)
- [UK's Endava Q3 revenue falls 8.4% on weak demand, posts goodwill impairment](https://longbridge.com/en/news/287210665.md)
- [Wegovy Liver Data Broadens Semaglutide Story For Novo Nordisk Investors](https://longbridge.com/en/news/286980981.md)
- [Canada and India now have generic Wegovy. Here's why the U.S. doesn't.](https://longbridge.com/en/news/287250894.md)
- [CDSCO asks states, UTs to monitor surrogate promotion for GLP-1 drugs](https://longbridge.com/en/news/286925029.md)